Scholarly Index
Robert A. Nicholson
Eli Lilly (United States); 5,269 total citations; 165 total publications; best world rank #270
Eli Lilly (United States)
5,269Total citations
165Total publications
43H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Migraine and Headache Studies | Lifetime | 270 | US 87 | 96.74 |
| Healthcare Decision-Making and Restraints | Lifetime | 452 | US 188 | 92.75 |
| Medical Malpractice and Liability Issues | Lifetime | 850 | US 465 | 90.78 |
| Psychopathy, Forensic Psychiatry, Sexual Offending | Lifetime | 495 | US 219 | 93.21 |
| Trigeminal Neuralgia and Treatments | Lifetime | 559 | US 188 | 91.71 |
| Psychological Testing and Assessment | Lifetime | 270 | US 177 | 88.93 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 494 | US 101 | 84.39 |
| Migraine and Headache Studies | 2021-2025 | 394 | US 101 | 87.93 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 304 | US 70 | 80.80 |